USD 84.74
(-0.94%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 974 Million USD | 190.75% |
2022 | 335 Million USD | -10.9% |
2021 | 376 Million USD | 170.81% |
2020 | -531 Million USD | 19.05% |
2019 | -656 Million USD | -188.99% |
2018 | -227 Million USD | -188.67% |
2017 | 256 Million USD | 250.59% |
2016 | -170 Million USD | -157.38% |
2015 | 296.27 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 223 Million USD | -10.08% |
2024 Q1 | 248 Million USD | -41.92% |
2023 Q2 | 169 Million USD | -2.87% |
2023 Q4 | 427 Million USD | 109.31% |
2023 Q3 | 204 Million USD | 20.71% |
2023 Q1 | 174 Million USD | 279.38% |
2023 FY | 974 Million USD | 190.75% |
2022 Q4 | -97 Million USD | -183.62% |
2022 FY | 335 Million USD | -10.9% |
2022 Q3 | 116 Million USD | -21.62% |
2022 Q1 | 168 Million USD | 20.86% |
2022 Q2 | 148 Million USD | -11.9% |
2021 Q1 | 84 Million USD | -11.58% |
2021 Q3 | 2 Million USD | -98.68% |
2021 FY | 376 Million USD | 170.81% |
2021 Q4 | 139 Million USD | 6850.0% |
2021 Q2 | 151 Million USD | 79.76% |
2020 Q4 | 95 Million USD | 164.63% |
2020 Q1 | -57 Million USD | 37.36% |
2020 Q2 | -422 Million USD | -640.35% |
2020 Q3 | -147 Million USD | 65.17% |
2020 FY | -531 Million USD | 19.05% |
2019 Q4 | -91 Million USD | -37.88% |
2019 Q2 | -390 Million USD | -257.8% |
2019 Q1 | -109 Million USD | 32.3% |
2019 FY | -656 Million USD | -188.99% |
2019 Q3 | -66 Million USD | 83.08% |
2018 Q2 | 15 Million USD | -43.4% |
2018 FY | -227 Million USD | -188.67% |
2018 Q4 | -161 Million USD | 22.22% |
2018 Q3 | -207 Million USD | -1480.0% |
2018 Q1 | 26.5 Million USD | -91.95% |
2017 Q4 | 329 Million USD | 0.0% |
2017 FY | 256 Million USD | 250.59% |
2016 FY | -170 Million USD | -157.38% |
2015 FY | 296.27 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
AptarGroup, Inc. | 284.48 Million USD | -242.371% |
Baxter International Inc. | 2.65 Billion USD | 63.328% |
Becton, Dickinson and Company | 1.72 Billion USD | 43.569% |
Bausch + Lomb Corporation | -260 Million USD | 474.615% |
Haemonetics Corporation | 117.55 Million USD | -728.527% |
Envista Holdings Corp | -100.2 Million USD | 1072.056% |
ResMed Inc. | 1.02 Billion USD | 4.599% |
Teleflex Incorporated | 356.32 Million USD | -173.344% |
Warby Parker Inc. | -63.19 Million USD | 1641.212% |
West Pharmaceutical Services, Inc. | 593.4 Million USD | -64.139% |